{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/hims-hers-health-hims/",
 "dataUrl": "https://clearank.com/stock/hims-hers-health-hims/data.json",
 "title": "Hims & Hers (HIMS) Stock Forecast & Price Target (2026)",
 "description": "Hims & Hers Health, Inc. (HIMS) stock: Healthcare, Drug Manufacturers - Specialty & Generic. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "Hims & Hers Health, Inc. (HIMS)",
 "published": "2026-06-27T09:20:02+00:00",
 "modified": "2026-09-11T20:03:31.146+00:00",
 "generated": "2026-09-11T21:17:13.307Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "HIMS",
  "name": "Hims & Hers Health, Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Drug Manufacturers - Specialty & Generic",
  "country": "United States",
  "website": "https://www.hims.com"
 },
 "quote": {
  "price": 27.52,
  "previousClose": 27.44,
  "change": 0.07,
  "changePercent": 0.27,
  "open": 27.2,
  "high": 27.62,
  "low": 26.735,
  "volume": 237756,
  "averageVolume": 8242736,
  "marketCap": 6402120052,
  "fiftyTwoWeekHigh": 65.299,
  "fiftyTwoWeekLow": 13.74,
  "marketOpen": false,
  "asOf": "2026-09-11T20:03:30.000Z"
 },
 "statistics": {
  "pe": -43.67,
  "eps": -0.63,
  "dividendYield": 0,
  "beta": 2.412,
  "priceToSales": 2.524888,
  "priceToBook": 20.086391,
  "revenueTtm": 2578112000,
  "grossMargin": 0.6383351876093647,
  "returnOnEquity": -0.32033002
 },
 "technicals": {
  "rsi": 28.09,
  "macd": -0.85,
  "sma50": 31.04,
  "sma200": 28.23,
  "rsiSignal": "Oversold",
  "trend": "Bullish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 58,
  "consensus": "Hold",
  "fairValue": 27.52,
  "analystTarget": 31,
  "analystCount": 15,
  "wallStreetConsensus": "Hold",
  "generatedAt": "2026-09-11T20:03:30.000Z",
  "priceAtAnalysis": 27.515,
  "volatility": {
   "daily": 5.15,
   "risk": "volatile"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 27.24,
  "aggressiveEntry": 27.52,
  "stopLoss": 24.92,
  "stopLossPercent": 8.5,
  "targets": [
   28.06,
   28.6,
   29.42
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 16.13,
    "base": 30.61,
    "upside90th": 58.11
   },
   {
    "year": 2028,
    "downside10th": 13.76,
    "base": 34.06,
    "upside90th": 84.3
   },
   {
    "year": 2029,
    "downside10th": 12.49,
    "base": 37.9,
    "upside90th": 114.98
   },
   {
    "year": 2030,
    "downside10th": 11.71,
    "base": 42.17,
    "upside90th": 151.9
   },
   {
    "year": 2031,
    "downside10th": 11.2,
    "base": 46.92,
    "upside90th": 196.61
   },
   {
    "year": 2032,
    "downside10th": 10.86,
    "base": 52.2,
    "upside90th": 250.81
   },
   {
    "year": 2033,
    "downside10th": 10.66,
    "base": 58.08,
    "upside90th": 316.46
   },
   {
    "year": 2034,
    "downside10th": 10.55,
    "base": 64.62,
    "upside90th": 395.83
   },
   {
    "year": 2035,
    "downside10th": 10.52,
    "base": 71.9,
    "upside90th": 491.59
   },
   {
    "year": 2036,
    "downside10th": 10.54,
    "base": 79.99,
    "upside90th": 606.89
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "HIMS Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$27.20",
    "Day Range": "$26.74 to $27.62",
    "Prev Close": "$27.44",
    "Volume": "237.8K",
    "52-Week Range": "$13.74 to $65.30",
    "Market Cap": "$6.40B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a significant premium to sector peers (+124%), suggesting market expectations for superior growth or market position."
   ]
  },
  {
   "id": "financials",
   "title": "HIMS Financial Performance",
   "text": [
    "Analysis: In the last 3 quarters, HIMS beat estimates 2 times. However, the stock fell 2 times the next day. This suggests positive news is often \"priced in\" or investors are selling the news."
   ]
  },
  {
   "id": "analysis",
   "title": "HIMS Analysis",
   "text": [
    "Hims & Hers Health, Inc. (HIMS) is exhibiting bearish momentum, trading below its 50-day SMA of $31.04 and its 200-day SMA of $28.23. The Relative Strength Index (RSI) is at 28.09, indicating oversold conditions, which could suggest a potential for a short-term bounce. However, the MACD is negative at -0.845, reinforcing the prevailing downward trend. Volume has been significantly below average, with the latest volume at 237,756 compared to an average of 8,242,736, suggesting a lack of conviction behind current price action.",
    "Insiders have sold $170.5 million worth of HIMS stock versus only $1.2 million in purchases, indicating a strong bearish sentiment from management.",
    "HIMS is trading below its 50-day SMA ($31.04) and 200-day SMA ($28.23), signaling a bearish technical trend and potential for further price declines.",
    "The company missed EPS estimates significantly in its latest two earnings reports, leading to notable stock price declines.",
    "Wall Street revenue estimates show strong year-over-year growth, with the current quarter projected at +49.00% and the next quarter at +54.00%.",
    "The outlook for Hims & Hers Health, Inc. (HIMS) is cautiously bearish in the near term, given the heavy insider selling and negative technical indicators. While the company continues to exhibit impressive revenue growth, outpacing sector averages, the persistent earnings misses and the significant disposition of shares by insiders suggest potential headwinds. The median Wall Street price target of $31 indicates limited upside, and the stock's position below key moving averages reinforces a bearish bias. Investors should monitor upcoming earnings reports and insider activity closely for any shifts in sentiment."
   ],
   "lists": {
    "ProTips": [
     "Given the heavy insider selling signal from HIMS, consider reducing exposure or waiting for a clearer bullish catalyst before initiating new positions.",
     "The oversold RSI reading of 28.09 suggests a potential for a short-term bounce, but this should be viewed with caution given the prevailing bearish trend and insider selling.",
     "With a negative EPS and recent earnings misses, it is advisable to scrutinize the company's path to profitability and its ability to sustain revenue growth."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Heavy Insider Selling Pressure",
     "text": "Insiders have sold $170.5 million worth of HIMS stock versus only $1.2 million in purchases, indicating a strong bearish sentiment from management.",
     "source": "Insider Trading Data"
    },
    {
     "type": "Bearish",
     "title": "Trading Below Key Moving Averages",
     "text": "HIMS is trading below its 50-day SMA ($31.04) and 200-day SMA ($28.23), signaling a bearish technical trend and potential for further price declines.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bearish",
     "title": "Recent Earnings Misses",
     "text": "The company missed EPS estimates significantly in its latest two earnings reports, leading to notable stock price declines.",
     "source": "Earnings Reports"
    },
    {
     "type": "Bullish",
     "title": "Strong Revenue Growth Projections",
     "text": "Wall Street revenue estimates show strong year-over-year growth, with the current quarter projected at +49.00% and the next quarter at +54.00%.",
     "source": "Wall Street Estimates"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Hims & Hers Health, Inc. (HIMS) exhibits a negative EPS of -0.63, making its P/E ratio mathematically negative and thus not a useful valuation metric. The company's revenue growth of 38.2% is strong, outpacing the sector average of 10.0%, and forward estimates show continued strong growth. Despite this top-line expansion, the significant insider selling totaling $170.5 million raises concerns about management's confidence in the current valuation. The median Wall Street price target of $31 suggests a limited upside from the current price, indicating that the market may be pricing in these concerns.",
    "Hims & Hers Health, Inc. (HIMS) most recently reported an EPS of -0.37 for the quarter ending August 10, 2026, missing the estimate of -0.05 by a significant 640% and leading to a 3.97% price drop. Prior to this, the company missed estimates in the May 11, 2026 quarter by 246.15%, resulting in a 14.1% stock decline. While there was a positive EPS surprise in February 2026, the recent trend indicates a pattern of earnings misses that could weigh on future performance.",
    "The primary risk for Hims & Hers Health, Inc. (HIMS) is the heavy insider selling signal, with over $170 million in sales by insiders, suggesting a lack of confidence in the current stock price. Additionally, the stock is trading below key moving averages (50-day and 200-day SMA), indicating a bearish technical trend and potential for further downside. The company's negative EPS and recent earnings misses also present a fundamental risk, despite strong revenue growth."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "6.40B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "N/A (Negative EPS)"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "-0.6300"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "65.30"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "13.74"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Oversold SMA Cross Bullish Price vs SMA Bearish MACD Bearish Golden Cross in effect with the 50-day SMA ($31.04) above the 200-day SMA ($28.23), price is trading below the 50-day SMA, RSI at 28.1 suggests oversold conditions; potential bounce setup."
   ],
   "facts": {
    "RSI": "Oversold",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "28.09"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-0.85"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "31.04"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "28.23"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.37",
    "Correlation with Nasdaq 100 (QQQ)": "+0.39",
    "Correlation with Bitcoin (BTC)": "+0.36",
    "Correlation with Gold (XAU)": "+0.09"
   }
  },
  {
   "id": "trade-plans",
   "title": "HIMS Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (28.1) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$28.06",
    "TARGET 2": "$28.60",
    "TARGET 3": "$29.42",
    "STOP LOSS": "$24.92"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+6.28%",
    "Average Feb return": "+4.36%",
    "Average Mar return": "-0.76%",
    "Average Apr return": "+0.93%",
    "Average May return": "+13.99%",
    "Average Jun return": "+2.00%",
    "Average Jul return": "+1.69%",
    "Average Aug return": "-10.68%",
    "Average Sep return": "+6.80%",
    "Average Oct return": "-6.64%",
    "Average Nov return": "+17.14%",
    "Average Dec return": "+1.15%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "5.15%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in HIMS in September 2019 would be worth about $28,000 today, compared with about $25,170 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in HIMS today could grow to about $29,073 by 2036 in the base case, with a bull case near $220,568 and a bear case around $3,832. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "HIMS Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $42.17 for HIMS by 2030 in the base case, from $27.52 today (1.5x over 4 years). The downside path ends near $11.71. These are outcomes of a Monte Carlo simulation run on HIMS's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using HIMS's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. HIMS is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "HIMS simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$16.13",
        "$30.61",
        "$58.11"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$13.76",
        "$34.06",
        "$84.30"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$12.49",
        "$37.90",
        "$115"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$11.71",
        "$42.17",
        "$152"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$11.20",
        "$46.92",
        "$197"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$10.86",
        "$52.20",
        "$251"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$10.66",
        "$58.08",
        "$316"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$10.55",
        "$64.62",
        "$396"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$10.52",
        "$71.90",
        "$492"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$10.54",
        "$79.99",
        "$607"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "CVS CVS Health Corporation NYSE $94.67 -0.6506%",
     "url": "https://clearank.com/stock/cvs-health-cvs/"
    },
    {
     "text": "REPL Replimune Group, Inc. NASDAQ $13.24 -8.37%",
     "url": "https://clearank.com/stock/repl-stock-analysis/"
    },
    {
     "text": "OFIX Orthofix Medical Inc. NASDAQ $8.91 +2.53%",
     "url": "https://clearank.com/stock/ofix-stock-analysis/"
    },
    {
     "text": "IQV IQVIA Holdings Inc. NYSE $257.30 +0.1245%",
     "url": "https://clearank.com/stock/iqvia-iqv/"
    },
    {
     "text": "DHR Danaher Corp. NYSE $200.53 -2.11%",
     "url": "https://clearank.com/stock/dhr-stock-analysis/"
    },
    {
     "text": "TLRY Tilray Brands Inc. NASDAQ $4.02 -3.02%",
     "url": "https://clearank.com/stock/tilray-brands-tlry/"
    },
    {
     "text": "BSX Boston Scientific Corp. NYSE $43.10 -4.14%",
     "url": "https://clearank.com/stock/boston-scientific-bsx/"
    },
    {
     "text": "CNC Centene Corp. NYSE $65.40 +2.09%",
     "url": "https://clearank.com/stock/centene-cnc/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "AAL vs DAL Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/aal-vs-dal/"
    },
    {
     "text": "VGT vs QQQM Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vgt-vs-qqqm/"
    },
    {
     "text": "COP vs OXY Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/cop-vs-oxy/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "HIMS Insider Trading Analysis",
   "facts": {
    "Bought": "$1.2M",
    "Sold": "$170.5M",
    "Insiders": "17",
    "Avg Transaction": "$1.7M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in HIMS",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Aug 7, 2025",
       "cells": [
        "DUDUM ANDREW Chief Executive Officer",
        "Sell",
        "660.0K",
        "$33.4M"
       ]
      },
      {
       "label": "Mar 2, 2023",
       "cells": [
        "BARD ALEX Director",
        "Sell",
        "2.8M",
        "$30.8M"
       ]
      },
      {
       "label": "Jun 17, 2025",
       "cells": [
        "DUDUM ANDREW Chief Executive Officer",
        "Sell",
        "240.8K",
        "$13.8M"
       ]
      },
      {
       "label": "Oct 16, 2025",
       "cells": [
        "DUDUM ANDREW Chief Executive Officer",
        "Sell",
        "175.7K",
        "$11.0M"
       ]
      },
      {
       "label": "Jun 3, 2024",
       "cells": [
        "CHI MICHAEL Officer",
        "Sell",
        "521.4K",
        "$10.3M"
       ]
      },
      {
       "label": "May 16, 2025",
       "cells": [
        "DUDUM ANDREW Chief Executive Officer",
        "Sell",
        "175.7K",
        "$10.3M"
       ]
      },
      {
       "label": "Feb 18, 2025",
       "cells": [
        "DUDUM ANDREW Chief Executive Officer",
        "Sell",
        "175.7K",
        "$10.2M"
       ]
      },
      {
       "label": "Sep 16, 2025",
       "cells": [
        "DUDUM ANDREW Chief Executive Officer",
        "Sell",
        "175.7K",
        "$9.4M"
       ]
      },
      {
       "label": "Jun 11, 2024",
       "cells": [
        "CHI MICHAEL Officer",
        "Sell",
        "392.2K",
        "$8.6M"
       ]
      },
      {
       "label": "Mar 18, 2025",
       "cells": [
        "DUDUM ANDREW Chief Executive Officer",
        "Sell",
        "254.4K",
        "$8.6M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Hims+%26+Hers+Health%2C+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is Hims & Hers Health, Inc.'s current stock price and consensus rating?",
   "answer": "As of September 11, 2026, Hims & Hers Health, Inc. (HIMS) is trading at $27.515. The consensus rating among 15 Wall Street analysts is 'Hold'."
  },
  {
   "question": "What is the median analyst price target for HIMS stock?",
   "answer": "The median analyst price target for Hims & Hers Health, Inc. (HIMS) is $31.00, implying an upside of 12.7% from the current price."
  },
  {
   "question": "What is the recent insider trading activity for HIMS?",
   "answer": "Insiders of Hims & Hers Health, Inc. (HIMS) have been net sellers, with total sales amounting to $170.5 million compared to $1.2 million in purchases, indicating a heavy sell signal."
  },
  {
   "question": "How is HIMS performing technically?",
   "answer": "Hims & Hers Health, Inc. (HIMS) is currently trading below its 50-day and 200-day moving averages ($31.04 and $28.23), with an RSI at 28.1 suggesting oversold conditions, but the MACD indicates bearish momentum."
  },
  {
   "question": "What are the revenue growth prospects for HIMS?",
   "answer": "Hims & Hers Health, Inc. (HIMS) has demonstrated strong year-over-year revenue growth of 38.2%, with Wall Street projecting continued acceleration to 49.00% for the current quarter and 54.00% for the next."
  },
  {
   "question": "What are the main risks facing Hims & Hers Health, Inc.?",
   "answer": "Key risks include significant insider selling pressure, a bearish technical trend indicated by price action below moving averages, and recent earnings misses despite strong revenue growth."
  },
  {
   "question": "What is HIMS stock forecast for 2030?",
   "answer": "Based on Monte Carlo simulations, Hims & Hers Health, Inc.'s (HIMS) stock forecast for 2030 shows a base case price of $42.17, with a downside projection of $11.71 and an upside projection of $151.9. These are statistical outcomes, not price targets."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "CVS",
    "name": "CVS Health Corporation NYSE",
    "price": "$94.67",
    "change": "-0.6506%",
    "url": "https://clearank.com/stock/cvs-health-cvs/"
   },
   {
    "ticker": "REPL",
    "name": "Replimune Group, Inc. NASDAQ",
    "price": "$13.24",
    "change": "-8.37%",
    "url": "https://clearank.com/stock/repl-stock-analysis/"
   },
   {
    "ticker": "OFIX",
    "name": "Orthofix Medical Inc. NASDAQ",
    "price": "$8.91",
    "change": "+2.53%",
    "url": "https://clearank.com/stock/ofix-stock-analysis/"
   },
   {
    "ticker": "IQV",
    "name": "IQVIA Holdings Inc. NYSE",
    "price": "$257.30",
    "change": "+0.1245%",
    "url": "https://clearank.com/stock/iqvia-iqv/"
   },
   {
    "ticker": "DHR",
    "name": "Danaher Corp. NYSE",
    "price": "$200.53",
    "change": "-2.11%",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "TLRY",
    "name": "Tilray Brands Inc. NASDAQ",
    "price": "$4.02",
    "change": "-3.02%",
    "url": "https://clearank.com/stock/tilray-brands-tlry/"
   },
   {
    "ticker": "BSX",
    "name": "Boston Scientific Corp. NYSE",
    "price": "$43.10",
    "change": "-4.14%",
    "url": "https://clearank.com/stock/boston-scientific-bsx/"
   },
   {
    "ticker": "CNC",
    "name": "Centene Corp. NYSE",
    "price": "$65.40",
    "change": "+2.09%",
    "url": "https://clearank.com/stock/centene-cnc/"
   }
  ],
  "comparisons": [
   {
    "ticker": "AAL vs DAL Comparison",
    "name": "",
    "url": "https://clearank.com/compare/aal-vs-dal/"
   },
   {
    "ticker": "VGT vs QQQM Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vgt-vs-qqqm/"
   },
   {
    "ticker": "COP vs OXY Comparison",
    "name": "",
    "url": "https://clearank.com/compare/cop-vs-oxy/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "EIS",
    "text": "iShares MSCI Israel ETF",
    "url": "https://clearank.com/etf/eis-etf-analysis/"
   },
   {
    "ticker": "GWRE",
    "text": "Guidewire Software Inc.",
    "url": "https://clearank.com/stock/gwre-stock-analysis/"
   },
   {
    "ticker": "ROST",
    "text": "Ross Stores Inc.",
    "url": "https://clearank.com/stock/rost-stock-analysis/"
   },
   {
    "ticker": "LUGDF",
    "text": "Lundin Gold Inc",
    "url": "https://clearank.com/stock/lugdf-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "EIGEN/USD",
    "text": "↑ 9.39%",
    "url": "https://clearank.com/crypto/eigen-usd-crypto-analysis/"
   },
   {
    "ticker": "EGLD/USD",
    "text": "↓ 9.23%",
    "url": "https://clearank.com/crypto/egld-usd-crypto-analysis/"
   },
   {
    "ticker": "AERO/USD",
    "text": "↑ 8.90%",
    "url": "https://clearank.com/crypto/aero-usd-crypto-analysis/"
   },
   {
    "ticker": "HUT",
    "text": "↑ 8.77%",
    "url": "https://clearank.com/stock/hut-stock-analysis/"
   },
   {
    "ticker": "MRNA",
    "text": "↑ 8.44%",
    "url": "https://clearank.com/stock/moderna-mrna/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "HCA",
    "text": "HCA Healthcare",
    "url": "https://clearank.com/stock/hca-healthcare-hca/"
   },
   {
    "ticker": "HUM",
    "text": "Humana Inc",
    "url": "https://clearank.com/stock/hum-stock-analysis/"
   },
   {
    "ticker": "IDXX",
    "text": "IDEXX",
    "url": "https://clearank.com/stock/idxx-stock-analysis/"
   },
   {
    "ticker": "TLRY",
    "text": "Tilray Brands, Inc.",
    "url": "https://clearank.com/stock/tilray-brands-tlry/"
   },
   {
    "ticker": "ZTS",
    "text": "Zoetis Inc.",
    "url": "https://clearank.com/stock/zts-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/06/hims-hers-health-hims.png",
     "url": "https://clearank.com/wp-content/uploads/2026/06/hims-hers-health-hims.png",
     "width": "1280",
     "height": "720",
     "caption": "Hims & Hers Health, Inc. (HIMS) stock price analysis chart for June 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/hims-hers-health-hims/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/hims-hers-health-hims/",
        "name": "Hims & Hers (HIMS) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/hims-hers-health-hims/#webpage",
     "url": "https://clearank.com/stock/hims-hers-health-hims/",
     "name": "Hims & Hers (HIMS) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-06-27T09:20:02+00:00",
     "dateModified": "2026-09-11T20:03:31+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/hims-hers-health-hims.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/hims-hers-health-hims/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Hims & Hers (HIMS) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-06-27T09:20:02+00:00",
     "dateModified": "2026-09-11T20:03:31+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Hims & Hers Health, Inc. (HIMS) stock: Healthcare, Drug Manufacturers - Specialty & Generic. AI rating, technicals, 2030 forecast and trade plans.",
     "name": "Hims & Hers (HIMS) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/hims-hers-health-hims/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/hims-hers-health-hims/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/hims-hers-health-hims.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/hims-hers-health-hims/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Hims & Hers Health, Inc. (HIMS)",
   "tickerSymbol": "HIMS",
   "url": "https://clearank.com/stock/hims-hers-health-hims/",
   "description": "AI-powered financial analysis for Hims & Hers Health, Inc. (HIMS) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NYSE",
   "offers": {
    "@type": "Offer",
    "price": 27.515,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/hims-hers-health-hims/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is Hims & Hers Health, Inc.'s current stock price and consensus rating?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "As of September 11, 2026, Hims & Hers Health, Inc. (HIMS) is trading at $27.515. The consensus rating among 15 Wall Street analysts is 'Hold'."
     }
    },
    {
     "@type": "Question",
     "name": "What is the median analyst price target for HIMS stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median analyst price target for Hims & Hers Health, Inc. (HIMS) is $31.00, implying an upside of 12.7% from the current price."
     }
    },
    {
     "@type": "Question",
     "name": "What is the recent insider trading activity for HIMS?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insiders of Hims & Hers Health, Inc. (HIMS) have been net sellers, with total sales amounting to $170.5 million compared to $1.2 million in purchases, indicating a heavy sell signal."
     }
    },
    {
     "@type": "Question",
     "name": "How is HIMS performing technically?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Hims & Hers Health, Inc. (HIMS) is currently trading below its 50-day and 200-day moving averages, with an RSI of 28.09 suggesting oversold conditions, but the MACD indicates bearish momentum."
     }
    },
    {
     "@type": "Question",
     "name": "What are the revenue growth prospects for HIMS?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Hims & Hers Health, Inc. (HIMS) has demonstrated strong year-over-year revenue growth of 38.2%, with Wall Street projecting continued acceleration to 49.00% for the current quarter and 54.00% for the next."
     }
    },
    {
     "@type": "Question",
     "name": "What are the main risks facing Hims & Hers Health, Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks include significant insider selling pressure, a bearish technical trend indicated by price action below moving averages, and recent earnings misses despite strong revenue growth."
     }
    },
    {
     "@type": "Question",
     "name": "What is HIMS stock forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, Hims & Hers Health, Inc.'s (HIMS) stock forecast for 2030 shows a base case price of $42.17, with a downside projection of $11.71 and an upside projection of $151.9. These are statistical outcomes, not price targets."
     }
    }
   ]
  }
 ]
}